IE44760B1 - A novel form of disoduim cromoglycate - Google Patents

A novel form of disoduim cromoglycate

Info

Publication number
IE44760B1
IE44760B1 IE183/77A IE18377A IE44760B1 IE 44760 B1 IE44760 B1 IE 44760B1 IE 183/77 A IE183/77 A IE 183/77A IE 18377 A IE18377 A IE 18377A IE 44760 B1 IE44760 B1 IE 44760B1
Authority
IE
Ireland
Prior art keywords
composition according
weight
disodium cromoglycate
composition
water
Prior art date
Application number
IE183/77A
Other languages
English (en)
Other versions
IE44760L (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE44760(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IE44760L publication Critical patent/IE44760L/xx
Publication of IE44760B1 publication Critical patent/IE44760B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IE183/77A 1976-01-30 1977-01-28 A novel form of disoduim cromoglycate IE44760B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (2)

Publication Number Publication Date
IE44760L IE44760L (en) 1977-07-30
IE44760B1 true IE44760B1 (en) 1982-03-24

Family

ID=26238506

Family Applications (1)

Application Number Title Priority Date Filing Date
IE183/77A IE44760B1 (en) 1976-01-30 1977-01-28 A novel form of disoduim cromoglycate

Country Status (14)

Country Link
JP (1) JPS5294411A (de)
AU (1) AU512593B2 (de)
DE (1) DE2703119A1 (de)
DK (2) DK154766C (de)
ES (1) ES455478A1 (de)
FI (1) FI770215A (de)
FR (1) FR2339604A1 (de)
IE (1) IE44760B1 (de)
IL (1) IL51314A (de)
LU (1) LU76661A1 (de)
NL (1) NL185446C (de)
NO (2) NO151860C (de)
NZ (1) NZ183157A (de)
SE (2) SE442268B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
JPS63138229U (de) * 1987-03-05 1988-09-12
JPS63138228U (de) * 1987-03-05 1988-09-12
EP0338670B1 (de) * 1988-03-22 1994-05-11 FISONS plc Pharmazeutische Mischungen
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
CA2421976C (en) * 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
ATE260641T1 (de) 1991-12-18 2004-03-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
WO2000006121A1 (de) 1998-07-24 2000-02-10 Jago Research Ag Medizinische aerosolformulierungen
ATE234604T1 (de) 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
HUE026884T2 (en) 2007-02-11 2016-08-29 Map Pharmaceuticals Inc DHE is a therapeutic method of administration for the rapid relief of migraine while minimizing side effects

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (de) * 1956-03-21 1900-01-01
BE556587A (de) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU512593B2 (en) 1980-10-16
DK156876C (da) 1990-03-12
SE7700888L (sv) 1977-07-31
FI770215A (de) 1977-07-31
JPS6129929B2 (de) 1986-07-10
NO780183L (no) 1977-08-02
DE2703119C2 (de) 1990-10-25
SE442267B (sv) 1985-12-16
NL185446B (nl) 1989-11-16
NZ183157A (en) 1979-08-31
JPS5294411A (en) 1977-08-09
AU2162677A (en) 1978-08-03
LU76661A1 (de) 1977-08-03
IE44760L (en) 1977-07-30
IL51314A (en) 1980-03-31
NO151860B (no) 1985-03-11
NL185446C (nl) 1990-04-17
DK357588D0 (da) 1988-06-29
FR2339604A1 (fr) 1977-08-26
DK154766B (da) 1988-12-19
DK38077A (da) 1977-07-31
DK357588A (da) 1988-06-29
DK154766C (da) 1989-05-22
IL51314A0 (en) 1977-03-31
ES455478A1 (es) 1978-02-01
SE442268B (sv) 1985-12-16
SE8107278L (sv) 1981-12-04
DE2703119A1 (de) 1977-08-04
NL7700911A (nl) 1977-08-02
FR2339604B1 (de) 1980-12-05
NO770286L (no) 1977-08-02
NO151860C (no) 1985-06-19
DK156876B (da) 1989-10-16

Similar Documents

Publication Publication Date Title
IE44760B1 (en) A novel form of disoduim cromoglycate
US5334374A (en) Pharmaceutical compositions containing pentamidine
US4405598A (en) Composition for treating asthma
US5204113A (en) Pharmaceutical compositions containing pentamidine
CA2074495C (en) Propellant compositions
RU2294737C2 (ru) Медицинские аэрозольные составы
CA2004598C (en) Medicinal aerosol formulations
US3014844A (en) Self-propelling powder dispensing compositions
KR100794060B1 (ko) 에어로졸 약제 조성물
CA2014401A1 (en) Aerosolised azole anti fungals
JP2508918B2 (ja) 可逆的閉塞性気道疾患治療剤
CA1176171A (en) Compositions containing the disodium salt of 1,3- bis(2-carboxychromon-5-yloxy)-propan-2-ol
GB1562901A (en) Disodium cromoglycate
CA1120401A (en) Composition containing the disodium salt of 1,3-bis(2-carboxychromon-5-yloxy)-propan-2-ol
WO1994004148A1 (en) Use of macrolide compounds for the treatment of reversible obstructive airways disease
US4847277A (en) Compound and treatment of obstructive airways disease therewith
CA1083963A (en) Use of flunisolide to treat respiratory diseases
NZ243056A (en) Aerosol formulation containing a medicament, tetrafluoroethane and isopropyl myristate

Legal Events

Date Code Title Description
MK9A Patent expired